Marty Makary: “Biosimilars are in both [Medicare] parts.”

“And so he's asking many of the stakeholder groups that he has access to to take a look at biosimilars. That includes Medicare Advantage plans, it includes Medicaid plans, it includes Medicare Part B and D. Biosimilars are in both [Medicare] parts. So I think, you know, we're not going to sugarcoat things. We're going to be very honest about what we see in the marketplace.” (25:52–25:55)

This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.